Перейти к содержимому

SEC Roundup Ep 103: The Delisting Cliff – How Nasdaq's $5M Rule Threatens Small Public Companies

Investor Choice Advocates Network

0:00 / 0:00

SEC Roundup Ep 103: The Delisting Cliff – How Nasdaq's $5M Rule Threatens Small Public Companies

1 191 просмотр · 2 недели назад
Investor Choice Advocates Network
220 подписчиков
1 191 просмотр · 2 недели назад
Fall below the line for thirty business days, and there's no climbing back — you're over the cliff. On July 22, 2026, the SEC approved a new Nasdaq rule requiring listed companies to keep a market value of at least $5 million. Any company that stays below that line for 30 consecutive business days faces immediate suspension and delisting — with no cure period to fix the shortfall and no stay of trading while it appeals. It is the first automatic, no-cure, no-stay listing trigger the Commission has ever approved. One week later it was on hold: after the Small Public Company Coalition and Cemtrex moved to challenge the approval, it was automatically stayed, and on August 5 the Coalition petitioned the full Commission to throw it out. In Episode 103 of SEC Roundup, co-hosts Nick Morgan and Tom Zaccaro sit down with Coalition president Marc Indeglia and former SEC Chief Economist Professor Craig Lewis to unpack what's at stake for small public companies and their investors. Professor Lewis examined every Nasdaq-listed company from 2006 to 2025 and asked a simple question: what would this rule actually have done? He found 816 companies it would have delisted — and 640 of them, roughly 78%, later recovered. Hundreds remain listed today, worth billions of dollars combined. His conclusion: one bad stretch below the line is not a reliable sign a company is finished. He also explains the "cliff." Because a suspended stock gets trapped in a thinner, less liquid market, investors race to sell before the threshold hits. That selling drives the price down, which makes delisting more likely, which pushes even more investors to sell — a self-fulfilling drop that can even invite manipulation by traders betting a company over the edge. Marc lays out what the Coalition's petition asks for and why it filed: a rule that, by Nasdaq's own admission, will delist companies that should have stayed listed, offering no real chance to cure and no pause before the damage is done. The panel walks through the better-tailored fixes already sitting in Nasdaq's own rulebook — a standard cure period, the ordinary stay pending appeal, a longer measurement window, and tailoring to the issuers that actually carry elevated risk — none of which the rule adopted. Key topics covered in Episode 103: • The rule in plain English: suspend and delist after 30 days below $5 million, with no cure and no stay pending appeal • Why the approval is currently frozen — and what the SPCC's petition asks the SEC to do Professor Lewis's 20-year data study: 816 companies swept in, 78% recovered • The "cliff": how a bright-line trigger becomes self-fulfilling and opens the door to manipulation • The better options Nasdaq already has — cure periods, stays, longer windows, risk-based tailoring • What it means for capital formation and small-cap investors if the rule takes effect Investor Choice Advocates Network (ICAN Law) is the only nonprofit public-interest litigation firm in the country focused exclusively on reining in SEC overreach and expanding fair access to capital markets. Be part of a movement to protect innovation and opportunity in American markets while preserving essential investor protections—join our email list today: https://www.icanlaw.org/newsletter-si... Background links: • SEC file & petition (SR-NASDAQ-2026-004): https://www.sec.gov/rules-regulations... (This is the SEC's official page for the rule. The SPCC's August 5 petition for review is posted here with the other petition letters — grab the direct PDF link from this page for the description. I couldn't isolate the exact petition-PDF URL to hard-code it, so use this hub link or the direct one off it.) • SPCC comment letter (Marc Indeglia, July 10, 2026): https://www.sec.gov/comments/SR-NASDA... • Professor Lewis's data report (Ex. A to SPCC's Feb. 19, 2026 letter): https://www.sec.gov/comments/sr-nasda... • SEC Approval Order (Release No. 34-105971, July 22, 2026): https://www.sec.gov/files/rules/sro/n... • ICAN newsletter sign-up (CTA): https://www.icanlaw.org/newsletter-si...